The Journal of Organic Chemistry
Note
6.5 Hz, 1H), 5.30 (d, J = 17.2 Hz, 1H), 5.18 (d, J = 10.3 Hz, 1H), 4.76
(q, J = 6.9 Hz, 1H), 3.74 (s, 3H), 3.70 (s, 3H), 3.03 (dd, J = 12.9, 7.0
Hz, 1H), 2.47 (dd, J = 12.9, 7.2 Hz, 1H), 2.36 (s, 3H). 13C NMR (101
MHz, CDCl3) δ 170.1, 169.3, 167.4, 141.0, 138.3, 130.2, 129.0, 128.8,
116.3, 72.5, 70.2, 53.3, 53.1, 42.9, 21.5. IR (film, cm−1): 3083, 3007,
2953, 1733, 1608, 1565, 1513, 1434, 1292, 1266, 1199, 1068, 991, 924,
826. HRMS (MALDI-TOF) m/z: [M + H]+ calcd for C17H20NO4,
302.1390; found, 302.1390.
calcd for C20H20NO4, 338.1392; found, 338.1390. For (+)-3m, αD25
+26.6 (c 1.0, MeOH).
Dimethyl 5-Methyl-2,5-diphenyl-4,5-dihydro-3H-pyrrole-
3,3-dicarboxylate (3n). 3n was prepared according to the general
procedure. Purification by column chromatography on neutral
aluminum oxide (100−300 mesh, petroleum ether/ethyl acetate,
1
20:1). Yield: 305 mg, 87%, white solid, mp 153−155 °C. H (400
MHz, CDCl3) δ 7.97−7.91 (m, 2H), 7.45−7.36 (m, 5H), 7.31 (t, J =
7.6 Hz, 2H), 7.27−7.18 (m, 1H), 3.76 (s, 3H), 3.45 (s, 3H), 3.04 (d, J
= 5.7 Hz, 2H), 1.66 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 170.3,
169.6, 165.7, 147.3, 133.3, 130.6, 129.0, 128.4, 128.3, 126.8, 125.5,
71.1, 53.3, 53.0, 50.5, 29.9. IR (film, cm−1): 2961, 2920, 2851, 1736,
1609, 1518, 1440, 1260, 1093, 1022, 800, 739, 695. HRMS (MALDI-
TOF) m/z: [M + H]+ calcd for C21H22NO4, 352.1549; found,
352.1551.
Dimethyl 2-(4-Methoxyphenyl)-5-vinyl-4,5-dihydro-3H-pyr-
role-3,3-dicarboxylate (3i). 3i was prepared according to the
general procedure except 2 equiv of 2i was used instead. Purification
by column chromatography on neutral aluminum oxide (100−300
mesh, petroleum ether/ethyl acetate, 10:1). Yield: 266 mg, 84%,
1
colorless oil. H (400 MHz, CDCl3) δ 7.86 (d, J = 8.7 Hz, 2H), 6.88
(d, J = 8.8 Hz, 2H), 5.98 (ddd, J = 17.0, 10.3, 6.7 Hz, 1H), 5.31 (d, J =
17.2 Hz, 1H), 5.19 (d, J = 10.2 Hz, 1H), 4.75 (dd, J = 13.6, 6.7 Hz,
1H), 3.84 (s, 3H), 3.73 (d, J = 15.0 Hz, 6H), 3.04 (dd, J = 12.9, 7.0 Hz,
1H), 2.47 (dd, J = 12.9, 7.2 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ
170.2, 169.4, 166.8, 161.6, 138.4, 130.6, 125.5, 116.2, 113.6, 72.4, 70.2,
55.4, 53.3, 53.2, 43.0. IR (film, cm−1): 1731, 1607, 1514, 1258, 913,
745. HRMS (MALDI-TOF) m/z: [M + H]+ calcd for C17H20NO5,
318.1341; found, 318.1339.
Dimethyl 2-(4-Chlorophenyl)-5-vinyl-4,5-dihydro-3H-pyr-
role-3,3-dicarboxylate (3j). 3j was prepared according to the
general procedure exept 2 equiv of 2j was used instead. Purification by
column chromatography on neutral aluminum oxide (100−300 mesh,
petroleum ether/ethyl acetate, 10:1). Yield: 260 mg, 81%, colorless oil.
1H (400 MHz, CDCl3) δ 7.83 (d, J = 8.7 Hz, 2H), 7.34 (d, J = 8.7 Hz,
Dimethyl 5-Benzyl-2-phenyl-4,5-dihydro-3H-pyrrole-3,3-di-
carboxylate (3o). 3o was prepared according to the general
procedure. Purification by column chromatography on neutral
aluminum oxide (100−300 mesh, petroleum ether/ethyl acetate,
1
20:1). Yield: 252 mg, 72%, yellow oil. H (400 MHz, CDCl3) δ 7.82
(d, J = 7.0 Hz, 2H), 7.41−7.15 (m, 8H), 4.45 (dt, J = 14.3, 7.0 Hz,
1H), 3.65 (d, J = 9.6 Hz, 6H), 3.31 (dd, J = 13.6, 5.7 Hz, 1H), 2.76
(ddd, J = 22.2, 13.4, 7.7 Hz, 2H), 2.35 (dd, J = 13.2, 7.5 Hz, 1H). 13C
NMR (101 MHz, CDCl3) δ 170.13, 169.24, 166.54, 138.68, 133.05,
132.53, 130.42, 129.36, 128.99, 128.70, 128.47, 128.13, 126.42, 72.25,
70.21, 53.09, 53.06, 42.06, 41.84. IR (film, cm−1): 2958, 2918, 1850,
1735, 1639, 1263, 1090, 1021, 801, 765, 697. HRMS (MALDI-TOF)
m/z: [M + H]+ calcd for C21H22NO4, 352.1549; found, 352.1549.
Dimethyl 2-Phenyl-3a,4,5,6,7,7a-hexahydro-3H-indole-3,3-
dicarboxylate (3p). 3p was prepared according to the general
procedure. Purification by column chromatography on neutral
aluminum oxide (100−300 mesh, petroleum ether/ethyl acetate,
2H), 5.98 (ddd, J = 17.0, 10.3, 6.5 Hz, 1H), 5.31 (dt, J = 17.3, 1.4 Hz,
1H), 5.21 (dt, J = 10.4, 1.3 Hz, 1H), 4.77 (q, J = 6.9 Hz, 1H), 3.76 (s,
3H), 3.72 (s, 3H), 3.09−3.01 (m, 1H), 2.48 (dd, J = 13.0, 7.3 Hz, 1H).
13C NMR (101 MHz, CDCl3) δ 169.7, 168.9, 137.5, 130.5, 128.7,
1
116.9, 72.3, 70.2, 53.5, 53.4, 42.6. IR (film, cm−1): 3009, 2961, 1716,
1645, 1611, 1251, 1077, 933, 775. HRMS (MALDI-TOF) m/z: [M]+
calcd for C16H16ClNO4, 321.0768; found, 321.0774.
20:1). Yield: 287 mg, 91%, colorless oil. H (400 MHz, CDCl3) δ
7.76−7.68 (m, 2H), 7.45−7.32 (m, 3H), 3.80 (s, 3H), 3.64 (s, 3H),
3.44 (td, J = 11.3, 3.6 Hz, 1H), 2.61−2.46 (m, 2H), 2.06−1.98 (m,
1H), 1.93 (d, J = 12.5 Hz, 1H), 1.89−1.82 (m, 1H), 1.60−1.31 (m,
5H). 13C NMR (101 MHz, CDCl3) δ 169.6, 169.4, 167.3, 134.0, 130.3,
128.2, 128.0, 73.4, 72.1, 56.9, 53.0, 52.7, 31.9, 26.5, 26.1, 25.6. IR (film,
cm−1): 3032, 2930, 2857, 1732, 1597, 1568, 1521, 1441, 1365, 1254,
1214, 1099, 1063, 1025, 915, 799, 774, 689. HRMS (MALDI-TOF)
m/z: [M + H]+ calcd for C18H22NO4, 315.1471; found, 315.1470.
Dimethyl 2-Phenyl-1-azaspiro[4.5]dec-1-ene-3,3-dicarboxy-
late (3q). 3q was prepared according to the general procedure.
Purification by column chromatography on neutral aluminum oxide
(100−300 mesh, petroleum ether/ethyl acetate, 20:1). Yield: 309 mg,
94%, colorless oil. 1H (400 MHz, CDCl3) δ 7.83 (d, J = 6.9 Hz, 2H),
7.42−7.30 (m, 3H), 3.72 (s, 6H), 2.63 (s, 2H), 1.81 (dd, J = 16.5, 9.9
Hz, 5H), 1.55−1.36 (m, 5H). 13C NMR (101 MHz, CDCl3) δ 170.5,
163.4, 133.5, 130.3, 128.9, 128.2, 75.6, 70.6, 53.2, 46.3, 37.9, 37.9, 25.6,
23.4. IR (film, cm−1): 2875, 1740, 1611, 1587, 1544, 1227, 1136, 1044,
915, 689. HRMS (MALDI-TOF) m/z: [M]+ calcd for C19H23NO4,
329.1627; found, 329.1633.
Dimethyl (E)-2-Styryl-5-vinyl-4,5-dihydro-3H-pyrrole-3,3-di-
carboxylate (3k). 3k was prepared according to the general
procedure. Purification by column chromatography on neutral
aluminum oxide (100−300 mesh, petroleum ether/ethyl acetate,
1
20:1). Yield: 275 mg, 88%, light brown oil. H (400 MHz, CDCl3) δ
7.51 (m, 3H), 7.41−7.31 (m, 3H), 6.93 (d, J = 16.3 Hz, 1H), 5.94
(ddd, J = 17.1, 10.3, 6.8 Hz, 1H), 5.37−5.26 (m, 1H), 5.19 (d, J = 10.3
Hz, 1H), 4.72 (d, J = 7.1 Hz, 1H), 3.80 (d, J = 1.4 Hz, 6H), 2.98 (dd, J
= 13.3, 7.3 Hz, 1H), 2.36 (dd, J = 13.3, 7.1 Hz, 1H).). 13C NMR (101
MHz, CDCl3) δ 169.5, 168.7, 138.3, 135.9, 129.4, 128.9, 127.8, 120.4,
116.6, 72.8, 70.6, 53.5, 53.4, 40.5. IR (film, cm−1): 3028, 3005, 2954,
2925, 1733, 1634, 1586, 1510, 1494, 1449, 1434, 1260, 1200, 1099,
1071, 1019, 992, 924, 799, 749, 699. HRMS (MALDI-TOF) m/z: [M
+ H]+ calcd for C18H20NO4, 314.1392; found, 314.1388.
Dimethyl 2-Phenyl-4,5-dihydro-3H-pyrrole-3,3-dicarboxy-
late (3l). 3l was prepared according to the general procedure at 40
°C instead of 25 °C. Purification by column chromatography on
neutral aluminum oxide (100−300 mesh, petroleum ether/ethyl
acetate, 20:1). Yield: 206 mg, 79%, colorless oil. The NMR data
coincided with the literature.19 1H NMR (400 MHz, CDCl3) δ 7.94−
7.79 (m, 2H), 7.46−7.32 (m, 3H), 4.12 (t, J = 6.7 Hz, 2H), 3.73 (s,
6H), 2.77 (t, J = 6.7 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 169.7,
167.6, 133.0, 130.4, 128.5, 128.2, 69.8, 59.3, 53.1, 37.2.
5′,5′-Dimethyl-2′-phenyl-4′,5′-dihydrospiro[indoline-3,3′-
pyrrol]-2-one (3r). 3r was prepared according to the general
procedure. Purification by column chromatography on neutral
aluminum oxide (100−300 mesh, petroleum ether/ethyl acetate,
1
10:1). Yield: 281 mg, 97%, white solid, mp 187−189 °C. H (400
MHz, CDCl3) δ 8.98−8.62 (br, s, 1H), 7.41 (d, J = 7.6 Hz, 2H), 7.29−
7.19 (m, 2H), 7.19−7.08 (m, 3H), 7.01 (t, J = 7.6 Hz, 1H), 6.92 (d, J =
7.8 Hz, 1H), 2.67 (d, J = 13.4 Hz, 1H), 2.24 (d, J = 13.4 Hz, 1H), 1.63
(d, J = 11.7 Hz, 6H). 13C NMR (101 MHz, CDCl3) δ 179.5, 140.5,
132.9, 130.6, 128.9, 128.5, 127.9, 123.9, 123.5, 110.5, 73.4, 67.5, 51.6,
31.2, 30.8. IR (film, cm−1): 2957, 2925, 2859, 1734, 1706, 1443, 1384,
1332, 1261, 1211, 1136, 1094, 1022, 913, 802, 759. HRMS (MALDI-
TOF) m/z: [M + H]+ calcd for C19H19N2O, 291.1497 found
291.1493.
Dimethyl 2,5-Diphenyl-4,5-dihydro-3H-pyrrole-3,3-dicar-
boxylate (3m). 3m was prepared according to the general procedure.
Purification by column chromatography on neutral aluminum oxide
(100−300 mesh, petroleum ether/ethyl acetate, 20:1). Yield: 306 mg,
1
91%, white solid, mp 134−136 °C. H (400 MHz, CDCl3) δ 7.91−
7.85 (m, 2H), 7.35−7.23 (m, 7H), 7.21−7.16 (m, 1H), 5.25 (dd, J =
8.5, 6.9 Hz, 1H), 3.69 (s, 3H), 3.55 (s, 3H), 3.26 (dd, J = 13.0, 6.9 Hz,
1H), 2.48 (dd, J = 13.0, 8.5 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ
170.0, 168.9, 167.8, 142.3, 132.9, 130.7, 128.8, 128.6, 128.2, 127.4,
126.7, 73.5, 70.7, 53.3, 53.1, 45.9. IR (film, cm−1): 3060, 3028, 2953,
1732, 1607, 1573, 1519, 1494, 1447, 1434, 1292, 1268, 1172, 1070,
1027, 967, 919, 796, 757, 695. HRMS (MALDI-TOF) m/z: [M + H]+
Methyl 4-Oxo-3-phenyl-1,4,5,6,7,7a-hexahydro-3aH-isoin-
dole-3a-carboxylate (3s). 3s was prepared according to the general
procedure. Purification by column chromatography on neutral
aluminum oxide (100−300 mesh, petroleum ether/ethyl acetate,
E
dx.doi.org/10.1021/jo402383a | J. Org. Chem. XXXX, XXX, XXX−XXX